Denmark is currently looking into whether it can share its Astrazeneca vaccines with developing countries, reveals the World Health Organization's (WHO) Regional Director for Europe Hans Kluge, according to Reuters.
This comes in the wake of Wednesday's announcement from the Danish Health Authority that it has removed the Astrazeneca vaccine from the Danish inoculation program due to a supposed link between the vaccine and a rare series of blood clot incidents.
More from MedWatch
In 2015, Genmab partnered with relatively unknown biotech firm Biontech. Reflecting on how far Genmab has come since, CEO Jan van de Winkel is still confident that partnerships, rather than acquisitions, are the way forward. If it had acquired Biontech at the time, the CEO speculates Genmab may have put a stop to other activities – including the Covid-19 vaccine efforts that went on to save millions of lives. This and fairness are worth remembering as biotech firms are increasingly strapped for cash, van de Winkel reflects.